Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative PET chemosensitivity testing in stage III colon cancer
2009-011445-13Phase 2Completed
- Sponsor
- Institut Jules Bordet
- Start
- Sep 2009
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of fluorouracil, oxaliplatin and folinic acid in colon adenocarcinoma, sponsored by Institut Jules Bordet. Primary endpoint: PET FDG uptake response predicting 3-year disease-free survival. Started Sep 2009; status: completed.
02
Drugs
fluorouraciloxaliplatinfolinic acid
03
Conditions
colon adenocarcinoma
Beyond the preview
Go deeper on 2009-011445-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011445-13.